Production (Stage)
cbdMD, Inc.
YCBD
$0.8579
-$0.0011-0.13%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.52% | -4.87% | -20.21% | -15.45% | -29.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.52% | -4.87% | -20.21% | -15.45% | -29.86% |
| Cost of Revenue | -0.32% | -5.78% | -2.74% | -22.14% | -19.27% |
| Gross Profit | 14.67% | -4.41% | -30.86% | -11.49% | -35.73% |
| SG&A Expenses | -10.61% | -24.64% | -31.26% | -32.10% | -25.09% |
| Depreciation & Amortization | -1.62% | 5.04% | -56.92% | -23.38% | -23.47% |
| Other Operating Expenses | -71.19% | -40.41% | -127.81% | -48.18% | -1.94% |
| Total Operating Expenses | -11.68% | -19.27% | -43.30% | -30.05% | -22.42% |
| Operating Income | 68.68% | 91.90% | 89.02% | 79.05% | -10.74% |
| Income Before Tax | 84.03% | 101.52% | 99.04% | 125.97% | -125.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.03% | 101.52% | 99.04% | 125.97% | -125.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.03% | 101.52% | 99.04% | 125.97% | -125.21% |
| EBIT | 68.68% | 91.90% | 89.02% | 79.05% | -10.74% |
| EBITDA | 84.14% | 127.07% | 98.70% | 92.99% | -12.21% |
| EPS Basic | 82.44% | 67.90% | 98.95% | 87.08% | 22.02% |
| Normalized Basic EPS | 85.51% | 95.43% | 98.32% | 85.60% | 48.50% |
| EPS Diluted | 82.44% | 67.90% | 98.94% | 87.08% | 22.15% |
| Normalized Diluted EPS | 85.51% | 95.43% | 98.32% | 85.60% | 48.50% |
| Average Basic Shares Outstanding | 110.32% | 53.74% | 552.31% | 50.96% | 120.04% |
| Average Diluted Shares Outstanding | 110.32% | 53.74% | 552.31% | 50.96% | 120.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |